The NRF2 inducer 4-Octyl itaconate inhibited pro-inflammatory cytokines (IL-6, IL-1b, TNFα) in PBMC of SLE patients (Tang et al. 2018). The gene discussed is IL6; the disease is systemic lupus erythematosus.